Langlois, Margaux
Grassot, Lény
Fournier, Baptiste
Trédan, Olivier
Dupuis, Carmen
Maire, Aurélia
Sueur, Annabelle
Praud, Delphine
Fervers, Béatrice
Pérol, Olivia
His, Mathilde
Funding for this research was provided by:
Institut National Du Cancer (2020-085)
Institut National Du Cancer (2020-085)
Institut National Du Cancer (2020-085)
Institut National Du Cancer (2020-085)
Institut National Du Cancer (2020-085)
Institut National Du Cancer (2020-085)
Institut National Du Cancer (2020-085)
Institut National Du Cancer (2020-085)
Institut National Du Cancer (2020-085)
Institut National Du Cancer (2020-085)
Institut National Du Cancer (2020-085)
Article History
Received: 12 November 2025
Accepted: 17 March 2026
First Online: 26 March 2026
Declarations
:
: The French ethics committee allowed the administration of the ALPHA questionnaire (17th November 2020). The DISCO trial protocol was approved by a French ethics committee (Comité de Protection des Personnes Est I, ID RCB 2017-A03360-53, 1st February 2018) and its database was reported to the French National Commission for Data Protection and Liberties (ref. MR-001 no. 2016177, 13th December 2016). The trial is registered on (NCT number: NCT03529383, 17th May 2018). The informed consent form signed by all patients randomized in the DISCO trial mentions the possibility of re-use the study data for other research purposes.
: Not applicable.
: The authors declare no competing interests.